Group One Trading’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-245,046
Closed -$1.52M – 7449
2026
Q2
$1.51M Buy
245,046
+35,439
+17% +$195K ﹤0.01% 2489
2026
Q1
$939K Sell
209,607
-114,379
-35% -$572K ﹤0.01% 2788
2025
Q4
$1.71M Buy
323,986
+275,986
+575% +$1.39M ﹤0.01% 2416
2025
Q3
$253K Buy
48,000
+9,141
+24% +$58K ﹤0.01% 4417
2025
Q2
$221K Buy
38,859
+27,470
+241% +$156K ﹤0.01% 4233
2025
Q1
$54.2K Buy
11,389
+6,489
+132% +$35.3K ﹤0.01% 5098
2024
Q4
$27.3K Buy
+4,900
New +$30.2K ﹤0.01% 5499
2024
Q3
– Sell
-6,283
Closed -$32.8K – 6544
2024
Q2
$26.6K Buy
6,283
+4,526
+258% +$23.1K ﹤0.01% 5015
2024
Q1
$12.7K Buy
1,757
+991
+129% +$6.28K ﹤0.01% 5725
2023
Q4
$3.84K Sell
766
-9,234
-92% -$40.6K ﹤0.01% 6612
2023
Q3
$42.1K Buy
+10,000
New +$37.8K ﹤0.01% 5267
2022
Q4
– Sell
-3,497
Closed -$11K – 7131
2022
Q3
$11K Buy
+3,497
New +$14.4K ﹤0.01% 6408
2021
Q2
– Sell
-335
Closed -$13.7K – 8070
2021
Q1
$16K Buy
+335
New +$18.5K ﹤0.01% 6841
2020
Q2
– Sell
-299
Closed -$20.7K – 5720
2020
Q1
$16K Sell
299
-1,357
-82% -$90.6K ﹤0.01% 4333
2019
Q4
$135K Buy
1,656
+192
+13% +$13.5K ﹤0.01% 3449
2019
Q3
$83K Buy
1,464
+11
+0.8% +$824 ﹤0.01% 3680
2019
Q2
$174K Buy
1,453
+440
+43% +$73.8K ﹤0.01% 2962
2019
Q1
$186K Buy
1,013
+89
+10% +$15.9K ﹤0.01% 2757
2018
Q4
$165K Buy
924
+860
+1,344% +$188K ﹤0.01% 2830
2018
Q3
$21K Buy
+64
New +$22.7K ﹤0.01% 4367
2018
Q2
– Sell
-71
Closed -$31K – 5026
2018
Q1
$26K Buy
71
+33
+87% +$12.3K ﹤0.01% 3976
2017
Q4
$15K Sell
38
-4,198
-99% -$1.74M ﹤0.01% 4243
2017
Q3
$1.81M Buy
4,236
+3,746
+764% +$1.01M 0.02% 1117
2017
Q2
$78K Sell
490
-63
-11% -$8.6K ﹤0.01% 3263
2017
Q1
$69K Sell
553
-123
-18% -$15.9K ﹤0.01% 3210
2016
Q4
$82K Buy
+676
New +$106K ﹤0.01% 2958
2015
Q4
– Sell
-215
Closed -$22K – 4682
2015
Q3
$22K Buy
+215
New +$28.5K ﹤0.01% 3981

Other funds holding ABEO

Group One Trading's ABEO Position: Q3 2026 in Review

Group One Trading sold out of Abeona Therapeutics (ABEO) in Q3 2026, closing a stake of 245,046 shares — an estimated $1.52M sold.

Group One Trading first reported a position in ABEO in Q3 2015 and held it in 27 quarters. The position peaked at $1.81M in Q3 2017. 116 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Group One Trading reported no remaining Abeona Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 245,046 Abeona Therapeutics shares in Q3 2026, an estimated $1.52M.
  • Group One Trading first reported a position in Abeona Therapeutics in Q3 2015 and held it in 27 quarters.
  • Group One Trading's Abeona Therapeutics position peaked at $1.81M in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.